19-17762834-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_015122.3(FCHO1):c.100G>A(p.Ala34Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Consequence
FCHO1
NM_015122.3 missense
NM_015122.3 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 3.36
Genes affected
FCHO1 (HGNC:29002): (FCH and mu domain containing endocytic adaptor 1) Enables AP-2 adaptor complex binding activity. Involved in clathrin coat assembly and clathrin-dependent endocytosis. Located in cytosol; nucleoplasm; and plasma membrane. Is active in clathrin-coated pit. Implicated in primary immunodeficiency disease. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.39104515).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCHO1 | NM_015122.3 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | ENST00000596536.6 | NP_055937.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCHO1 | ENST00000596536.6 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | 5 | NM_015122.3 | ENSP00000470731.1 | ||
FCHO1 | ENST00000699212.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/30 | ENSP00000514208.1 | ||||
FCHO1 | ENST00000594202.6 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | 5 | ENSP00000473001.1 | |||
FCHO1 | ENST00000596309.6 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | 4 | ENSP00000470511.2 | |||
FCHO1 | ENST00000596951.6 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | 5 | ENSP00000472417.1 | |||
FCHO1 | ENST00000600209.6 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | 5 | ENSP00000469075.2 | |||
FCHO1 | ENST00000600676.5 | c.100G>A | p.Ala34Thr | missense_variant | 4/28 | 2 | ENSP00000470493.1 | |||
FCHO1 | ENST00000699176.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | ENSP00000514179.1 | ||||
FCHO1 | ENST00000699177.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | ENSP00000514180.1 | ||||
FCHO1 | ENST00000699207.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | ENSP00000514204.1 | ||||
FCHO1 | ENST00000699209.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | ENSP00000514206.1 | ||||
FCHO1 | ENST00000699215.1 | c.100G>A | p.Ala34Thr | missense_variant | 4/28 | ENSP00000514211.1 | ||||
FCHO1 | ENST00000699202.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | ENSP00000514200.1 | ||||
FCHO1 | ENST00000699214.1 | c.100G>A | p.Ala34Thr | missense_variant | 4/28 | ENSP00000514210.1 | ||||
FCHO1 | ENST00000699208.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/28 | ENSP00000514205.1 | ||||
FCHO1 | ENST00000699198.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/29 | ENSP00000514196.1 | ||||
FCHO1 | ENST00000699199.1 | c.100G>A | p.Ala34Thr | missense_variant | 4/28 | ENSP00000514197.1 | ||||
FCHO1 | ENST00000699213.1 | c.100G>A | p.Ala34Thr | missense_variant | 4/28 | ENSP00000514209.1 | ||||
FCHO1 | ENST00000699197.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/28 | ENSP00000514195.1 | ||||
FCHO1 | ENST00000699200.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/28 | ENSP00000514198.1 | ||||
FCHO1 | ENST00000699196.1 | c.100G>A | p.Ala34Thr | missense_variant | 5/27 | ENSP00000514194.1 | ||||
FCHO1 | ENST00000699203 | c.-51G>A | 5_prime_UTR_variant | 3/22 | ENSP00000514201.1 | |||||
FCHO1 | ENST00000699201.1 | n.100G>A | non_coding_transcript_exon_variant | 5/28 | ENSP00000514199.1 | |||||
FCHO1 | ENST00000699205.1 | n.100G>A | non_coding_transcript_exon_variant | 5/27 | ENSP00000514202.1 | |||||
FCHO1 | ENST00000699206.1 | n.100G>A | non_coding_transcript_exon_variant | 5/29 | ENSP00000514203.1 | |||||
FCHO1 | ENST00000699210.1 | n.100G>A | non_coding_transcript_exon_variant | 5/28 | ENSP00000514207.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 14, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with FCHO1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with threonine at codon 34 of the FCHO1 protein (p.Ala34Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T;T;T;T;.;T;T;T;T;.;.;.;T;T;.;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;D;D;D;D;.;D;D;D;D;D;D;D;D;.;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;.;.;.;.;L;.;.;.;.;.;.;.;.;L;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
Sift
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
T;T;T;D;D;D;D;T;D;D;D;D;D;D;D;D;T;D;T
Polyphen
1.0
.;D;D;.;.;.;.;D;.;.;.;.;.;.;.;.;D;.;.
Vest4
MutPred
Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);Loss of stability (P = 0.0696);.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.